000			02070 a2200553 4500
005			20250517001401.0
264		0	_c20150622
008			201506s 0 0 eng d
022			_a1432-1335
024	7		_a10.1007/s00432-014-1859-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aSöderlund Leifler, K
245	0	0	_aThe RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer. _h[electronic resource]
260			_bJournal of cancer research and clinical oncology _cMay 2015
300			_a797-804 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aCytosine
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGenotype
650	0	4	_aGuanine
650	0	4	_aHumans
650	0	4	_aMastectomy, Segmental
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xprevention & control
650	0	4	_aPolymerase Chain Reaction _xmethods
650	0	4	_aPolymorphism, Restriction Fragment Length
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrognosis
650	0	4	_aRad51 Recombinase _xgenetics
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aSequence Analysis, DNA
650	0	4	_aTreatment Outcome
700	1		_aAsklid, A
700	1		_aFornander, T
700	1		_aStenmark Askmalm, M
773	0		_tJournal of cancer research and clinical oncology _gvol. 141 _gno. 5 _gp. 797-804
856	4	0	_uhttps://doi.org/10.1007/s00432-014-1859-0 _zAvailable from publisher's website
999			_c24314890 _d24314890